Direct Response Marketing (Jersey) Limited, jersey, channel islands. Mail Order Online Pharmacy.
Viagra, Propecia, Cialis, Uprima, Xenical, Avodart, Regaine (Minoxidil). Treatments for impotence, hair loss and weight loss.  
Viagra, Propecia, Cialis, British Online Pharmacy. Viagra online ordering. Viagra, Propecia, Cialis, British Online Pharmacy. Viagra online ordering.
Viagra, Propecia, Cialis, British Online Pharmacy. Viagra online ordering.
Viagra, Propecia, Cialis, British Online Pharmacy. Viagra online ordering.
Viagra, Propecia, Cialis, British Online Pharmacy. Viagra online ordering.
Viagra, Propecia, Cialis, British Online Pharmacy. Viagra online ordering.
 All major Credit Cards accepted
Viagra, Propecia, Cialis, British Online Pharmacy. Viagra online ordering.
Viagra, Propecia, Cialis, British Online Pharmacy. Viagra online ordering.
Viagra, Propecia, Cialis, British Online Pharmacy. Viagra online ordering.
Viagra, Propecia, Cialis, British Online Pharmacy. Viagra online ordering.
Viagra, Propecia, Cialis, British Online Pharmacy. Viagra online ordering.
SAME DAY DESPATCH - FAST DELIVERY - GUARANTEED (NOT INCLUDING HOLIDAYS/WEEKENDS)
CALL OUR ORDER HOTLINE - 0845 121 6667 International - (44) 1534 510271
Viagra, Propecia, Cialis, British Online Pharmacy. Viagra online ordering.
Viagra, Propecia, Cialis, British Online Pharmacy. Viagra online ordering.
Viagra, Propecia, Cialis, British Online Pharmacy. Viagra online ordering.
  To view Products and prices, please; REGISTER
Viagra, Propecia, Cialis, British Online Pharmacy. Viagra online ordering.
  ED (IMPOTENCE) TREATMENTS
Impotence treatment drug. British Online Pharmacy.
  Buy Viagra
  Buy Cialis
  Buy Spedra
  Buy Levitra
  Buy Sildenafil
  Buy Nipatra
  Buy Vitaros
Impotence treatment drug. British Online Pharmacy.
  HAIR LOSS TREATMENTS
Impotence treatment drug. British Online Pharmacy.
  Buy Propecia
  Buy Avodart
  Buy Regaine
Xenical Sales pharmacy. Xenical online ordering.
  WEIGHT LOSS TREATMENTS
Xenical Sales pharmacy. Xenical online ordering.
  Buy Xenical
HRT Sales pharmacy. HRT online ordering.
  HORMONE (HRT) TREATMENTS
HRT Sales pharmacy. HRT online ordering.
  Buy HRT
  Climagest
  Climaval
  Climesse
  Elleste Duet
  Evorel
  Evorel Conti
  Evorel Sequi
  Femoston
  Femseven Sequi
  Indivina
  Kliofem
  Kliovance
  Mirena IUD
  Oestrogel
  Gynest Cream
  Ovestin cream
  Premarin
  Prempack C
  Livial
  Premique
  Tridestra
  Trisequens
Viagra Cost. Propecia cost. Cialis cost. British Online Pharmacy. Cheapest Drugs.
HRT Sales pharmacy. HRT online ordering.
  ORAL CONTRACEPTIVES
HRT Sales pharmacy. HRT online ordering.
  Buy OCP
  Buy Cilest 63
  Buy Dianette 63
  Buy Logynon 63
  Buy Marvelon 63
  Buy Mercilon 63
  Buy
  Buy Microgynon 63
  Buy Micronor 63
  Buy Yasmin 63
  Buy Levonelle
  Prices
Viagra, Propecia, Cialis, British Online Pharmacy. Viagra online ordering.
  Information page
Terms and conditions etc
  Contact
Viagra, Propecia, Cialis, British Online Pharmacy. Viagra online ordering.
  Customer comments
Registered Pharmacy sales
   
Viagra, Propecia, Cialis, British Online Pharmacy. Viagra online ordering.
Viagra, Propecia, Cialis, British Online Pharmacy. Viagra online ordering.
     

    PRILIGY - NOW AVAILABLE FROM DRM

    Men suffering from premature ejaculation can now, for the first time, take a pill that reportedly triples the time to climax, as Janssen-Cilag's Priligy has become available from DRM via a special Internet service.

    While the drug is not specifically licensed to combat premature ejaculation in the UK (a marketing application has not yet been submitted), it is approved for this use in several other European countries and is thus available over here too, but only after an online consultation with a doctor.

    As from this week, men suffering from premature ejaculation, which is thought to affect around 30% of the male population at some point in their lives, can get their hands on the Priligy (dapoxetine) by completing an online form for a private prescription for the drug, if suitable.

    Originally marketed as an antidepressant, Priligy is a short-acting selective serotonin reuptake inhibitor that works by altering the levels of serotonin - the hormone responsible for ejaculation - in the brain to give men a greater degree of control, and trials in more than 6,000 patients showed that it can increase the time to ejaculation by a factor of three.

    Before the arrival of Priligy, which comes in packs of three and costs roughly 30 a pill (including prescription etc), the only therapies men with premature ejaculation had available to them was a variety of local anaesthetic sprays and creams, condoms (to reduce sensitivity), counselling and certain ‘behavioural techniques’ to help delay orgasm, and so news of a new treatment will be very welcome indeed.

    Same potential as Viagra?
    "Priligy has the potential to do as much for men's sexual health as Viagra, as it will give sufferers a chance to improve the quality of their relationships and their general wellbeing," said Nitin Makadia, head of male sexual health. "It has been well received by men elsewhere in Europe".

    According to findings of a European study, more than half of men suffering from premature ejaculation have not spoken to anyone about their condition, of which almost half said they were too embarrassed to seek help and another 28% felt it wasn't a 'proper' medical condition and therefore untreatable.

    But the hope is that, by enabling patients to receive treatment without the need for a face-to-face consultation, more men will be prompted to get help for the condition.

     

     

     

     

     

     

    Priligy First Oral Prescription Medication Approved for PE BEERSE, Belgium, February 10


    BEERSE, Belgium, February 10 /PRNewswire-FirstCall/ -- Janssen-Cilag EMEA, a division of Janssen Pharmaceutica N. V., announced today that Priligy(TM) (dapoxetine) has received marketing authorisation in Finland and Sweden for the on-demand treatment of premature ejaculation (PE) in men 18-64 years of age. These approvals follow the positive outcome of a decentralised marketing authorisation procedure in seven European Union countries: Sweden, Austria, Finland, Germany, Spain, Italy and Portugal. The procedure was finalised in December 2008, and Finland and Sweden are the first countries worldwide to grant marketing authorisation for this compound. National approvals and licenses in the other five European countries are expected to follow. Dapoxetine is not approved for marketing in the United States.

    Dapoxetine is a drug specifically developed for the on-demand treatment of PE and is the first oral medication (tablet) to be approved for this condition. Dapoxetine has been extensively evaluated in five randomised, placebo-controlled Phase III clinical trials involving more than 6,000 men with PE and their partners. This is the largest and most comprehensive clinical trial programme to date for a drug therapy to treat PE. Dapoxetine is a unique, short-acting, selective serotonin reuptake inhibitor (SSRI) designed to be taken only when needed, that is 1-3 hours before sexual intercourse is anticipated, rather than every day.

    Dapoxetine will be marketed by Janssen-Cilag, marking another significant advance in the company's commitment to developing innovative, high quality treatments for unmet medical needs.

    Premature Ejaculation

    PE is a distressing sexual dysfunction that can be present from the first sexual encounter or can develop later in life. Depending on the methodology and criteria used to evaluate the prevalence of PE in studies, the reported proportion of men affected with this condition at some point in their lives has ranged from 4-30%. Experts in PE from the International Society of Sexual Medicine (ISSM) define the condition as consisting of three major components: a short time to ejaculation (prior to or within about one minute), lack of ejaculatory control and negative personal impact or distress related to ejaculation. Unlike erectile dysfunction (ED), which tends to affect older men, PE has similar prevalence across all age groups. In fact, more men are believed to experience PE than ED.

    A combination of physiological and psychological factors are believed to influence the mechanism of ejaculation. Men with PE appear to go through the same process of ejaculation as other men, but it happens more quickly and with a reduced feeling of control. Research suggests serotonin plays a central role in the timing of ejaculation.

    About dapoxetine

    ALZA Corporation, a Janssen-Cilag affiliate, licensed dapoxetine from PPD-GenuPro in 2001 with exclusive worldwide rights to develop and commercialise the compound for urogenital therapies, including premature ejaculation.

    The clinical trial programme for the use of dapoxetine in premature ejaculation was conducted by Johnson & Johnson Pharmaceutical Research and Development. The product will be marketed by Janssen-Cilag in most countries where regulatory approval has been granted.

    Product Availability

    After approval in a specific country, Priligy (dapoxetine) will only be available by prescription from a healthcare professional.

    The product is expected to be made available for purchase in licensed pharmacies in the countries where approved around April 2009, after all local regulatory requirements related to packaging and pricing are finalised. Janssen-Cilag will provide official confirmation of the exact date of product availability in each individual country. Applications for marketing authorisation in other countries are under review.

    Unapproved imitations (counterfeit) of dapoxetine have been sold. Government officials from around the world have warned of the potential risks associated with counterfeit drugs, including the risk of death. As for any prescription medication, patients should buy Priligy (dapoxetine) only from a pharmacy that is officially licensed by government authorities. Patients should be especially cautious of internet pharmacies, as many of these are unlicensed.

    About Janssen-Cilag

    The Janssen-Cilag companies are part of the Johnson & Johnson family of companies. They have a long track record in developing and marketing treatments for central nervous system disorders, pain management, oncology, infectious diseases, reproductive health and gastrointestinal disorders. More information about Janssen-Cilag can be found at http://www.janssen-cilag.com.

    Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) J&JPRD is part of the Johnson & Johnson family of companies. J&JPRD is headquartered in Raritan, NJ, and has facilities throughout Asia, Europe and the United States. J&JPRD is leveraging drug discovery and drug development in a variety of therapeutic areas to address unmet medical needs worldwide.

    (This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialise, actual results could vary materially from Janssen-Cilag's expectations and projections. Risks and uncertainties include general industry conditions and competition; economic conditions, such as interest rate and currency exchange rate fluctuations; technological advances and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approvals; domestic and foreign health care reforms and governmental laws and regulations; and trends toward health care cost containment. A further list and description of these risks, uncertainties and other factors can be found in Exhibit 99 of Johnson & Johnson's Annual Report on Form 10-K for the fiscal year ended December 31, 2007. Copies of this Form 10-K, as well as subsequent filings, are available online at http://www.sec.gov, www.jnj.com or on request from Johnson & Johnson. Janssen-Cilag does not undertake to update any forward-looking statements as a result of new information or future events or developments.)

    SOURCE Janssen-Cilag

     


    PRODUCT INFORMATION : OTHER PRODUCTS? : LOST? - SITE MAP : DRM HOME
     

    Direct Response Marketing (Jersey) Limited.

    Suite 15 Burlington House, St Saviours Road, St Helier, Jersey, British Channel Islands. JE2 4LA
    Telephone; 0845 121 6667 (UK local rate)
    Fax; 0845 121 6669 (UK local rate)
    International Telephone (44) 1534 510271

    General Enquiries - email: Email DRM: Order Enquiries - email: Email order dept
    All trademarks are acknowledged as the property of their respective owners.


89.145.89.36